Brief: Talaris Therapeutics Announces Leadership Transition

Tourmaline Bio

26/05/2023 12:12

May 26 (Reuters) - Talaris Therapeutics Inc  TALS.O :
    * TALARIS THERAPEUTICS ANNOUNCES LEADERSHIP TRANSITION
    * TALARIS THERAPEUTICS INC - APPOINTMENT OF MARY KAY FENTON
AS
INTERIM CHIEF EXECUTIVE OFFICER AND PRESIDENT EFFECTIVE AS OF
TODAY
    * TALARIS THERAPEUTICS INC - APPOINTMENT OF MARY KAY FENTON
AS
INTERIM CHIEF EXECUTIVE OFFICER AND PRESIDENT EFFECTIVE AS OF
TODAY
    * TALARIS THERAPEUTICS INC - APPOINTMENT OF MARY KAY FENTON
AS
INTERIM CHIEF EXECUTIVE OFFICER AND PRESIDENT EFFECTIVE AS OF
TODAY
    * TALARIS THERAPEUTICS INC - FENTON, WHO WILL CONTINUE AS
TALARIS'S CHIEF FINANCIAL OFFICER, SUCCEEDS CHIEF EXECUTIVE
OFFICER SCOTT REQUADT

Source text for Eikon:  ID:nGNX1PlgvR 
Further company coverage:  TALS.O 

 ((Reuters.Briefs@thomsonreuters.com;))